NCT01692808View on ClinicalTrials.gov

Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Crohn's Disease
Interventions
DRUG

Vitamin D3 3000 UI daily

Vitamin D3 will be administered as an adjunct to corticosteroids or enteral nutrition at the doses of 3000 UI daily or 4000 UI daily

DRUG

Vitamin D3 4000 UI daily

This arm is intended for those at diagnosis treated with Corticosteroid or in Remission

Trial Locations (1)

H3T1C5

Mother-child university hospital, Montreal

All Listed Sponsors
lead

St. Justine's Hospital

OTHER

NCT01692808 - Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease | Biotech Hunter | Biotech Hunter